COMPANY

Synvivia

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $856K (SBIR Phase II 5R44GM158472-02, continuation, notice May 7, 2026). NIH RePORTER 5R44GM158472-02 (May 7, 2026)
Evidence (1 event)
- May 7, 2026 · NIH RePORTER 5R44GM158472-02
  Organization: SYNVIVIA, INC.; City/State: Emeryville, CA; Project number: 5R44GM158472-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-07; FY total cost (award amount): 856268; Administering IC: National Institute of General Medical Sciences; Project title: Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

May 7, 2026 Grant Government grant — SBIR: $856,268 (annual award, as published), announced May 7, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Dec 6, 2024 Grant Government grant — SBIR: $1.64M (annual award, as published), announced Dec 6, 2024. Agency: NIH/NIGMS. Source: government award database. source ↗

Last 2 years.

May 7, 2026 Government grant — SBIR: $856,268 (annual award, as published), announced May 7, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Dec 6, 2024 Government grant — SBIR: $1.64M (annual award, as published), announced Dec 6, 2024. Agency: NIH/NIGMS. Source: government award database. source ↗